Press release
CD BioSciences Launches Innovative Immune System Tissue Microarrays for Research Usage
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is excited to announce the launch of its new Immune System Tissue Microarrays [https://www.bioimagingtech.com/immune-system-tissue-microarrays.html] for the scientific community to study the complex interactions of the immune system in various tissues. These innovative products offer researchers a powerful tool to unravel the complexities of the immune system and accelerate the development of new therapies.
Tissue microarray is a recent innovation in the field of pathology. This versatile technology for automated data analysis facilitates retrospective and prospective human tissue studies. It is a practical and effective tool for high-throughput molecular analysis of tissues, helping to identify new diagnostic and prognostic markers and targets for human cancers, with a wide range of potential applications in basic research, tumor prognosis and drug discovery.
Immune System Tissue Microarrays from CD BioSciences are meticulously designed to feature a variety of tissue cores, allowing researchers to simultaneously analyze the expression of multiple immune markers in a variety of tissues and providing invaluable information for understanding the distribution, function and interactions of immune cells. These tissue microarrays offer unparalleled efficiency, reproducibility, and versatility, making them an essential asset for advancing immunology research.
For example, the Lymphoma with Normal Tissue Microarray (Catalog NO. IMCT024) is a valuable resource for researchers studying lymphoma. This comprehensive collection includes 192 cases of lymphoma and normal tissue, organized into 96 core samples. It's designed for use in various histological techniques such as immunohistochemistry (IHC) and in situ hybridization (ISH), and other routine procedures.
The microarray offers a diverse range of lymphoma subtypes, including diffuse B-cell lymphoma, Burkitt lymphoma, follicular lymphoma, Hodgkin's lymphoma, Lennart lymphoma, mucosa-associated lymphoma, anaplastic large cell lymphoma, angio-immunoblastoid lymphadenopathy T-cell lymphoma, T-cell lymphoma, plasma cell lymphoma, and normal lymph node tissue. Each case is represented by duplicate nuclear cores, providing ample material for analysis.
In addition, the Non-Hodgkin's Lymphoma Tissue Microarray 4, 80 Cases, 42 Cores (Catalog NO. IMCT038) is a microarray focused on non-Hodgkin's lymphoma tissues that can be applied in IHC, ISH and other routine histology procedures. The microarray includes a diverse range of non-Hodgkin's lymphoma subtypes, including B-cell lymphoma, B small non-cleaved cell lymphoma, large B-cell lymphoma, B large cleaved cell lymphoma, B large non-cleaved cell lymphoma, B small cleaved cell lymphoma, mucosa-associated B-cell lymphoma, T-cell lymphoma, lymphocytic plasmacytoid lymphoma, and anaplastic large cell lymphoma. Each case of lymphoma in the microarray has duplicate cores, while there are 3 cases of normal lymph node tissue and 1 case of placenta tissue, each with a single core.
CD BioSciences is dedicated to providing researchers with the highest quality tools and services to advance their scientific endeavors. These cutting-edge Immune System Tissue Microarrays offer researchers a comprehensive and efficient solution to accelerate their immune system research. For more information about the products and other custom solutions from CD BioSciences, please visit https://www.bioimagingtech.com/immune-system-tissue-microarrays.html.
About CD BioSciences
CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules.
Media Contact
Company Name: CD BioSciences
Contact Person: Michelle Moser
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-biosciences-launches-innovative-immune-system-tissue-microarrays-for-research-usage]
State: New York
Country: United States
Website: https://www.bioimagingtech.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD BioSciences Launches Innovative Immune System Tissue Microarrays for Research Usage here
News-ID: 3671100 • Views: …
More Releases from ABNewswire
Advanced AC and DC Cooling Fans for the Automotive Industry
In the rapidly evolving automotive industry, efficient thermal management is critical for maintaining the performance and longevity of electronic systems and equipment. Our high-quality AC cooling fans [https://www.hekangfan.com/cross-flow-fan-product/] and DC cooling fans [https://www.hekangfan.com/dc-blower-fan-12025-product/] are engineered to meet these demands, offering reliable solutions for a wide range of automotive applications.
Image: https://www.hekangfan.com/uploads/applications04.jpg
Featuring a brushless DC motor, our fans deliver low noise and high-performance operation, ensuring quiet and efficient cooling even in demanding…
Tubular Steel Supplies LSAW Pipes for Iconic Advertising Tower Project in Hungar …
In Hungary, a landmark urban project is taking shape - a striking advertising tower designed to become a new visual symbol in the city's skyline. The structure is being built with Tubular Steel's premium Lsaw Pipe [https://www.tubularpiles.com/lsaw-pipe/]s, fully compliant with EN1090 and EN10210 standards, ensuring exceptional strength, precision, and durability.
Image: https://ecdn6.globalso.com/upload/p/1755/image_product/2025-01/p1_1-1.webp
The project uses pipes with specifications of 1600mm diameter, a wall thickness of 30mm, and a length of 8.7 meters,…
HZS Series Semi-Top Mounted Concrete Mixing Plant
Product Overview
RTZK semi overhead concrete Mixing Plant [https://www.rtzkglobal.com/mixing-plant/] is a new type of concrete mixing plant that falls between traditional mixing plants and overhead mixing plants. The semi top-mounted concrete mixing plant adopts a cement silo side structure, which saves more space than traditional mixing plants and is faster to install than overhead mixing plants, providing customers with an additional choice. Since its withdrawal, it has been highly favored by…
HZSY Series Integral Concrete Mixing Plant
Product Overview
RTZK Integral Concrete Mixing Plant [https://www.rtzkglobal.com/mixing-plant/] is a newly created product based on the existing fixed concrete mixing plant, combined with our company's years of experience in producing concrete mixing plants [https://www.rtzkglobal.com/concrete-mixing-plant/], and tailored to specific domestic and international needs. It integrates material storage, dosing, conveying, mixing, unloading, and fully automatic control systems into a single trailer unit, which has the characteristics of compact and reasonable structure, convenient transfer,and…
More Releases for BioSciences
Nanostructured Drug Market Poised for Growth with Advancements in Targeted Deliv …
Nanostructured Drug Market Overview
Nanostructured Drug Market is projected to grow significantly during the forecast period, driven by advancements in nanotechnology and increasing demand for targeted drug delivery systems.
The latest report (2025-2032) on the Nanostructured Drug Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods for accuracy. The report also…
CRISPR-Based Diagnostics Market for Infectious Diseases & Cancer Detection By 20 …
Global CRISPR-Based Diagnostics Market reached at a CAGR during the forecast period 2024-2031.
Crispr-Based Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate…
CRISPR-Based Diagnostics Market: Global Type, Trends, Service, Growth, Opportuni …
The CRISPR-Based Diagnostics Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/crispr-based-diagnostics-market
What is the projected…
CRISPR Based Diagnostics Market Growing Rapidly by 2031 - Sherlock Biosciences, …
DataM Intelligence has published a new research report on "CRISPR Based Diagnostics Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF…
Glycated Albumin Market to See Booming Growth 2024-2031 | Lifespan Biosciences, …
Glycated Albumin Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "Glycated Albumin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Glycated Albumin market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful…
Congenital Adrenal Hyperplasia Market to Witness Growth by 2032, Estimates Delve …
DelveInsight's "Congenital Adrenal Hyperplasia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Congenital Adrenal Hyperplasia, historical and forecasted epidemiology as well as the Congenital Adrenal Hyperplasia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Congenital Adrenal Hyperplasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here:
https://www.delveinsight.com/sample-request/congenital-adrenal-hyperplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of…
